mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy Research

Background:

• Tumor radioresistance is a major challenge in cancer radiotherapy.
• High mTOR signaling levels in tumors correlate with radioresistance.
• Cancer cells exhibit enhanced antioxidant mechanisms contributing to radioresistance.

Purpose of the Study:

• To review the relationship between mTOR signaling and antioxidant mechanisms in tumor radioresistance.
• To explore how mTOR signaling influences the Keap1-NRF2-xCT pathway and glutathione induction.
• To identify potential therapeutic adjuvants to improve radiotherapy efficacy.

Main Methods:

• Literature review focusing on mTOR signaling, antioxidant pathways, and radioresistance.
• Analysis of the Keap1-NRF2-xCT pathway's role in glutathione synthesis.
• Synthesis of findings to connect mTOR activity with cellular antioxidant defenses.

Main Results:

• mTOR signaling is implicated in promoting tumor radioresistance.
• mTOR pathway activation enhances cellular antioxidant capacity, particularly glutathione production.
• The Keap1-NRF2-xCT pathway is a key mediator linking mTOR to antioxidant defenses.

Conclusions:

• Targeting the mTOR pathway is a promising strategy to sensitize solid tumors to radiotherapy.
• Inhibiting mTOR may reduce the enhanced antioxidant mechanisms that drive radioresistance.
• Understanding the mTOR-antioxidant axis can guide the development of novel radiotherapy adjuvants.